| Product Code: ETC7323718 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ghana Clinical Oncology Next Generation Sequencing Market Overview |
3.1 Ghana Country Macro Economic Indicators |
3.2 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Ghana Clinical Oncology Next Generation Sequencing Market - Industry Life Cycle |
3.4 Ghana Clinical Oncology Next Generation Sequencing Market - Porter's Five Forces |
3.5 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.7 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ghana Clinical Oncology Next Generation Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ghana |
4.2.2 Growing awareness about the benefits of next generation sequencing in oncology |
4.2.3 Government initiatives to improve healthcare infrastructure and access to advanced technologies in oncology |
4.3 Market Restraints |
4.3.1 High cost associated with next generation sequencing technology |
4.3.2 Limited expertise and resources for implementing and interpreting NGS in clinical oncology in Ghana |
5 Ghana Clinical Oncology Next Generation Sequencing Market Trends |
6 Ghana Clinical Oncology Next Generation Sequencing Market, By Types |
6.1 Ghana Clinical Oncology Next Generation Sequencing Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Targeted Sequencing, 2021- 2031F |
6.1.6 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Resequencing, 2021- 2031F |
6.2 Ghana Clinical Oncology Next Generation Sequencing Market, By Workflow |
6.2.1 Overview and Analysis |
6.2.2 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Pre-Sequencing, 2021- 2031F |
6.2.3 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Sequencing, 2021- 2031F |
6.2.4 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.3 Ghana Clinical Oncology Next Generation Sequencing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Screening, 2021- 2031F |
6.3.3 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.3.4 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ghana Clinical Oncology Next Generation Sequencing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.4.5 Ghana Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
7 Ghana Clinical Oncology Next Generation Sequencing Market Import-Export Trade Statistics |
7.1 Ghana Clinical Oncology Next Generation Sequencing Market Export to Major Countries |
7.2 Ghana Clinical Oncology Next Generation Sequencing Market Imports from Major Countries |
8 Ghana Clinical Oncology Next Generation Sequencing Market Key Performance Indicators |
8.1 Number of clinical oncology facilities in Ghana adopting next generation sequencing technology |
8.2 Percentage increase in the number of oncology patients opting for next generation sequencing tests |
8.3 Improvement in turnaround time for NGS results in clinical oncology settings in Ghana |
9 Ghana Clinical Oncology Next Generation Sequencing Market - Opportunity Assessment |
9.1 Ghana Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Ghana Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.3 Ghana Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Ghana Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ghana Clinical Oncology Next Generation Sequencing Market - Competitive Landscape |
10.1 Ghana Clinical Oncology Next Generation Sequencing Market Revenue Share, By Companies, 2024 |
10.2 Ghana Clinical Oncology Next Generation Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here